Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 10,379 | 42,841 | 16,027 | 31,228 | 16,148 | -- |
| General And Administrative Expense | 10,379 | 42,841 | 16,027 | 31,228 | 16,148 | -- |
| Operating Expense | 10,379 | 42,841 | 16,027 | 31,228 | 16,148 | -- |
| Operating Income | -10,379 | -42,841 | -16,027 | -31,228 | -16,148 | -- |
| EBIT | -17,636 | -238,190 | -8,028 | -36,805 | 136,074 | -- |
| Interest Expense | 1,395 | 553.00 | 321.00 | 347.00 | 411.00 | -- |
| Interest Expense Non Operating | 1,395 | 553.00 | 321.00 | 347.00 | 411.00 | -- |
| Net Interest Income | -1,395 | -553.00 | -321.00 | -347.00 | -411.00 | -- |
| Other Income Expense | -7,257 | -195,349 | 7,999 | -5,577 | 152,222 | -- |
| Other Non Operating Income Expenses | -- | 232.00 | -- | 1,255 | -- | -- |
| Special Income Charges | 0.00 | -195,107 | 0.00 | 0.00 | 147,607 | -- |
| Gain On Sale Of Security | -7,257 | -474.00 | 7,999 | -6,832 | 4,615 | -- |
| Pretax Income | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 22,833 | -- |
| Net Income From Continuing And Discontinued Operation | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Income From Continuing Operation Net Minority Interest | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Income Including Noncontrolling Interests | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Income Common Stockholders | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Income | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| EBITDA | -17,636 | -238,190 | -8,028 | -36,805 | 136,074 | -- |
| Normalized EBITDA | -10,379 | -42,609 | -16,027 | -29,973 | -16,148 | -- |
| Basic EPS | 0.00 | -- | 0.00 | 0.00 | 0.00 | -- |
| Diluted EPS | 0.00 | -- | 0.00 | 0.00 | 0.00 | -- |
| Basic Average Shares | 31.5M | -- | 31.5M | 31.5M | 31.1M | -- |
| Diluted Average Shares | 31.5M | -- | 31.5M | 31.5M | 31.1M | -- |
| Total Unusual Items | -7,257 | -195,581 | 7,999 | -6,832 | 152,222 | -- |
| Total Unusual Items Excluding Goodwill | -7,257 | -195,581 | 7,999 | -6,832 | 152,222 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | -- |
| Normalized Income | -11,774 | -43,162 | -16,348 | -30,320 | 6,274 | -- |
| Diluted NI Availto Com Stockholders | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Income Continuous Operations | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Non Operating Interest Income Expense | -1,395 | -553.00 | -321.00 | -347.00 | -411.00 | -- |
| Other Gand A | 10,379 | 42,841 | 16,027 | 31,228 | 16,148 | -- |
| Other Special Charges | -- | 195,107 | -- | -- | -147,607 | -- |
| Total Expenses | 10,379 | 42,841 | 16,027 | 31,228 | 16,148 | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 4,344 | 28,804 | 22,737 | 108,711 | 134,458 | -- |
| Cash Cash Equivalents And Short Term Investments | 4,344 | 28,804 | 22,737 | 108,711 | 134,458 | -- |
| Cash Financial | 4,344 | 28,804 | 22,737 | 108,711 | 134,458 | -- |
| Receivables | 1,263 | 795.00 | 4,403 | 2,964 | 2,069 | -- |
| Prepaid Assets | 0.00 | 1,250 | 1,250 | 1,250 | 1,250 | -- |
| Current Assets | 5,607 | 30,849 | 28,390 | 112,925 | 137,777 | -- |
| Gross PPE | 4.4M | 4.4M | 4.4M | -- | 4.4M | 4.4M |
| Accumulated Depreciation | -4.3M | -4.3M | -4.3M | -- | -4.3M | -4.3M |
| Net PPE | 90,006 | 90,006 | 89,583 | 89,583 | 89,583 | -- |
| Other Non Current Assets | 37,700 | 37,700 | 37,700 | -- | -- | -- |
| Total Non Current Assets | 127,706 | 127,706 | 127,283 | 89,583 | 89,583 | -- |
| Total Assets | 133,313 | 158,555 | 155,673 | 202,508 | 227,360 | -- |
| Current Debt | 20,049 | -- | -- | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 20,049 | -- | -- | -- | -- | -- |
| Accounts Payable | 137,439 | 166,202 | 382,042 | 420,528 | 133,565 | -- |
| Payables | 522,359 | 548,619 | 382,042 | 420,528 | 408,228 | -- |
| Payables And Accrued Expenses | 522,359 | 548,619 | 382,042 | 420,528 | 408,228 | -- |
| Current Liabilities | 542,408 | 548,619 | 382,042 | 420,528 | 408,228 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 542,408 | 548,619 | 382,042 | 420,528 | 408,228 | -- |
| Common Stock | 16.9M | 16.9M | 16.8M | 16.8M | 16.8M | -- |
| Capital Stock | 16.9M | 16.9M | 16.8M | 16.8M | 16.8M | -- |
| Retained Earnings | -20.1M | -20.1M | -19.8M | -19.8M | -19.8M | -- |
| Common Stock Equity | -409,095 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Stockholders Equity | -409,095 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Total Equity Gross Minority Interest | -409,095 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Total Capitalization | -409,095 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Net Tangible Assets | -409,095 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Tangible Book Value | -409,095 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Working Capital | -536,801 | -517,770 | -353,652 | -307,603 | -270,451 | -- |
| Invested Capital | -389,046 | -390,064 | -226,369 | -218,020 | -180,868 | -- |
| Total Debt | 20,049 | -- | -- | -- | -- | -- |
| Net Debt | 15,705 | -- | -- | -- | -- | -- |
| Share Issued | 31.5M | 31.5M | 31.5M | 31.5M | 31.5M | -- |
| Ordinary Shares Number | 31.5M | 31.5M | 31.5M | 31.5M | 31.5M | -- |
| Dueto Related Parties Current | 384,920 | 382,417 | -- | -- | 274,663 | 484,413 |
| Other Current Borrowings | 20,049 | -- | -- | -- | -- | -- |
| Other Equity Interest | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | -- |
| Taxes Receivable | 1,263 | 795.00 | 4,403 | 2,964 | 2,069 | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -44,460 | 6,681 | -48,274 | -25,747 | -28,492 | -- |
| Cash Flow From Continuing Operating Activities | -44,460 | 6,681 | -48,274 | -25,747 | -28,492 | -- |
| Change In Working Capital | -25,478 | 56,086 | -31,654 | 4,471 | -23,654 | -- |
| Change In Receivables | -468.00 | 3,608 | -1,439 | -895.00 | 5,528 | -- |
| Change In Payables And Accrued Expense | -26,260 | 52,478 | -30,215 | 5,366 | -29,179 | -- |
| Change In Payable | -26,260 | 52,478 | -30,215 | 5,366 | -29,179 | -- |
| Other Non Cash Items | 49.00 | -- | -- | -- | -- | -- |
| Capital Expenditure | -- | -423.00 | -- | -- | -11,564 | -- |
| Purchase Of PPE | 0.00 | -423.00 | 0.00 | -- | -11,564 | -- |
| Net PPE Purchase And Sale | 0.00 | -423.00 | 0.00 | -- | -8,634 | -- |
| Investing Cash Flow | 0.00 | -423.00 | -37,700 | 0.00 | -8,634 | -- |
| Cash Flow From Continuing Investing Activities | 0.00 | -423.00 | -37,700 | 0.00 | -8,634 | -- |
| Net Issuance Payments Of Debt | 20,000 | -- | -- | -- | 0.00 | -- |
| Financing Cash Flow | 20,000 | -- | -- | -- | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | 20,000 | -- | -- | -- | 0.00 | -- |
| Changes In Cash | -24,460 | 6,067 | -85,974 | -25,747 | -37,126 | -- |
| Beginning Cash Position | 28,804 | 22,737 | 108,711 | 134,458 | 171,584 | -- |
| End Cash Position | 4,344 | 28,804 | 22,737 | 108,711 | 134,458 | -- |
| Free Cash Flow | -44,460 | 6,258 | -48,274 | -25,747 | -40,056 | -- |
| Change In Prepaid Assets | 1,250 | 0.00 | 0.00 | 0.00 | -3.00 | -- |
| Net Foreign Currency Exchange Gain Loss | 0.00 | -5,769 | -8,271 | 6,934 | 7,106 | -- |
| Net Income From Continuing Operations | -19,031 | -238,743 | -8,349 | -37,152 | 135,663 | -- |
| Net Other Investing Changes | -- | 0.00 | -37,700 | -- | -- | -- |
| Net Short Term Debt Issuance | 20,000 | -- | -- | -- | 0.00 | -- |
| Operating Gains Losses | -- | 189,338 | -8,271 | 6,934 | -140,501 | 1,768 |
| Sale Of PPE | 0.00 | -- | -- | -- | 2,930 | -- |